Publication | Closed Access
Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients.
30
Citations
19
References
2015
Year
MVC may constitute a new therapeutic option to prevent obesity and related disorders in HIV-infected patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1